Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Intestinal permeability in type 1 diabetes: An updated comprehensive overview

    Research output: Contribution to journalReviewResearchpeer-review

  2. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A Dual Systems Genetics Approach Identifies Common Genes, Networks, and Pathways for Type 1 and 2 Diabetes in Human Islets

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Human pathways in animal models: possibilities and limitations

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIMS/HYPOTHESIS: The incidence of type 1 diabetes is increasing more rapidly than can be explained by genetic drift. Viruses may play an important role in the disease, as they seem to activate the 2'-5'-linked oligoadenylate (2'-5'A) pathway of the innate antiviral immune system. Our aim was to investigate this possibility.

METHODS: Innate antiviral immune pathways were searched for type 1 diabetes-associated polymorphisms using genome-wide association study data. SNPs within ±250kb flanking regions of the transcription start site of 64 genes were examined. These pathways were also investigated for type 1 diabetes-associated RNA expression profiles using laser-dissected islets from two to five tissue sections per donor from the Diabetes Virus Detection (DiViD) study and the network of Pancreatic Organ Donors (nPOD).

RESULTS: We found 27 novel SNPs in genes nominally associated with type 1 diabetes. Three of those SNPs were located upstream of the 2'-5'A pathway, namely SNP rs4767000 (p = 1.03 × 10 -9, OR 1.123), rs1034687 (p = 2.16 × 10 -7, OR 0.869) and rs739744 (p = 1.03 × 10 -9, OR 1.123). We also identified a large group of dysregulated islet genes in relation to type 1 diabetes, of which two were novel. The most aberrant genes were a group of IFN-stimulated genes. Of those, the following distinct pathways were targeted by the dysregulation (compared with the non-diabetic control group): OAS1 increased by 111% (p < 1.00 × 10 -4, 95% CI -0.43, -0.15); MX1 increased by 142% (p < 1.00 × 10 -4, 95% CI -0.52, -0.22); and ISG15 increased by 197% (p = 2.00 × 10 -4, 95% CI -0.68, -0.18).

CONCLUSIONS/INTERPRETATION: We identified a genetic predisposition in the 2'-5'A pathway that potentially contributes to dysregulation of the innate antiviral immune system in type 1 diabetes. This study describes a potential role for the 2'-5'A pathway and other components of the innate antiviral immune system in beta cell autoimmunity.

Original languageEnglish
Issue number8
Pages (from-to)1805-1815
Number of pages11
Publication statusPublished - Aug 2021

Bibliographical note

Funding Information:
The DiViD study was funded by the South-Eastern Norway Regional Health Authority, the Novo Nordisk Foundation, and through the PEVNET (Persistent Virus Infection in Diabetes Network) Study Group funded by the European Union’s Seventh Framework Program (FP7/2007-2013) under grant agreement no. 261441 PEVNET. Additional grant support was from the National Institutes of Health (UC4 DK104155) and the JDRF (47-2013-520). nPOD, a collaborative type 1 diabetes research project, is sponsored by the JDRF (grant no. 25-2013-268, 25-2012-380 and 25-2007-874). Lastly, the study was supported by Bagger-Sørensen Foundation.

Publisher Copyright:
© 2021, The Author(s).

Copyright 2021 Elsevier B.V., All rights reserved.

    Research areas

  • 2′-5′ Oligoadenylate synthetase, 2′-5′A pathway, Interferon α, Ribonuclease L, RNase L, Toll-like receptor 7, Type 1 diabetes, Type 1 interferon, Type 2 diabetes, Virus

ID: 66517730